Buscar
Filtrado por:
Contribuyente
GlaxoSmithKline
Eliminar la restricciónContribuyente: GlaxoSmithKline
Fecha
2015
Eliminar la restricciónFecha: 2015
1 - 7 de 7
El número de resultados a mostrar por página
Resultados de la búsqueda
Select an image to start the slideshow
The use of structure-based drug design to optimise protein-ligand interactions
1 of 7
New route investigation and process development in the synthesis of GSK221149
2 of 7
Pharmacological characterisation of small molecule RGD-mimetics targeting αvβ6-mediated activation of TGFβ in idiopathic pulmonary fibrosis
3 of 7
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
4 of 7
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
5 of 7
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
6 of 7
The design, synthesis and optimisation of CCR4 antagonists for the treatment of asthma
7 of 7